November 16, 2015
Skin care specialist LEO Pharma acquires Japanese Astellas for € 675 million
LEO Pharma and Japanese pharmaceutical company Astellas Pharma Inc. have entered into an Asset Purchase Agreement under which Astellas will transfer its global dermatology business to LEO Pharma for € 675 million.